Sign in Subscribe
Pharmaceutical industry

Advanced Cell Technology Inc. Investment Report Highlights Biotech Industry Players

Strategic Insights

— 1 min read

Advanced Cell Technology Inc. (ACTC) has been featured in an investment report by StockPreacher.com, providing financial and investment analysis, analyst consensus, and industry information. The report is of particular interest to other biotech companies, including Geron Corp. (GERN), StemCells Inc. (STEM), and Aastrom Biosciences Inc. (ASTM). The report highlights ACTC's stem cell research programs, including the hemangioblast (HG) cell program, which investigates the possibility of using stem cells to treat cardiovascular disease, stroke, and cancer.

Key Takeaways:

  • ACTC is a biotechnology company focused on regenerative medicine, with a primary focus on cellular reprogramming, reduced complexity program, and stem cell differentiation research programs.
  • The Company develops adult stem cell-based products targeting therapies for heart and other cardiovascular diseases.
  • ACTC has published positive data in the journal NATURE Methods for its HG cellular program and expects to file an IND over the short term.
  • The Company has developed a novel technique to generate embryonic stem-cell lines without destroying embryos, a breakthrough in the ethical debate surrounding the industry.
  • ACTC owns or licenses more than 380 patents and patent applications in support of its research and applications.
  • The hemangioblast (HG) cell program investigates the possibility of using stem cells to treat cardiovascular disease, stroke, and cancer.
  • The report emphasizes the importance of ACTC's research programs in the biotech industry, particularly in the area of regenerative medicine.

Statistics:

  • ACTC owns or licenses more than 380 patents and patent applications in support of its research and applications.
  • The Company has announced the successful development of a novel technique to generate embryonic stem-cell lines without destroying embryos.
  • The HG cellular program has published positive data in the journal NATURE Methods.

Sources:

  • StockPreacher.com
  • Comtex SmarTrend Alert
  • GlobeNewswire
  • NATURE Methods

Read more